Cellular receptor for enterovirus D68

肠道病毒 D68 的细胞受体

基本信息

项目摘要

 DESCRIPTION (provided by applicant): The picornavirus enterovirus D-68 (EV-D68) is an icosahedral non-enveloped virus that was responsible for an outbreak of respiratory disease in the United States during 2014. During these outbreaks, acute flaccid paralysis similar to that caused by poliovirus was reported to correlate with EV-D68 infection in young children, suggesting that the virus might invade the central nervous system. EV-D68 is therefore an emerging human pathogen of medical significance. Like most other viruses, EV-D68 entry into the cell requires a receptor molecule. Two different cell receptors, sialic acid and decay-accelerating factor (DAF/CD55) have been reported to mediate EV-D68 entry. Replication of the NY68 and Fermon strains of EV-D68 in HeLa and A549 cells was unaffected by either neuraminidase treatment or the presence of antibodies against the SCR1 or SCR3 regions of DAF. However, infection by the Peru 68 strain in both cell lines was sensitive to treatment of cells with neuraminidase. These data suggest that more than one cell specific molecule is required for EV-D68 entry and that the molecule depends on the virus genotype. The goal of this proposal is to carry out a genetic screen for genes encoding molecules that participate in cell entry of EV-D68. To identify the cell receptor for EV-D68 we propose to genetically alter a population of cells using CRISPR-Cas9 methodology prior to infection with EV-D68, and identify those cells that no longer support viral replication. From this list of candidate genes, we will determine which molecule(s) functions during the early steps of viral replication: cell attachment, cell entry and viral uncoating using various tools including previous published work and bioinformatics. Cells determined to have disruptions in genes encoding transmembrane proteins and proteins with known characteristics to other picornavirus receptor proteins will be complemented by re-introducing the wild type gene into the corresponding altered cell. Cell binding and susceptibility to infection with multiple EV- D68 genotypes will be assessed by viral replication. If more than one cell protein is identified to mediate EV- D68 infection, we will refie our understanding of the virus-receptor interaction, by studying chimeric viruses in which the capsid coding region has been exchanged between the different genotypes.
 描述(由申请方提供):小核糖核酸病毒肠道病毒D-68(EV-D 68)是一种二十面体无包膜病毒,是2014年美国呼吸道疾病爆发的原因。在这些爆发中,据报道,类似于脊髓灰质炎病毒引起的急性弛缓性麻痹与幼儿感染EV-D 68有关,这表明该病毒可能侵入中枢神经系统。因此,EV-D 68是一种新兴的具有医学意义的人类病原体。像大多数其他病毒一样,EV-D 68进入细胞需要受体分子。据报道,两种不同的细胞受体,唾液酸和衰变加速因子(CD 55)介导EV-D 68进入。在HeLa和A549细胞中,EV-D 68的NY 68和Fermon株的复制不受神经氨酸酶处理或针对ESTA 1的SCR 1或SCR 3区域的抗体的存在的影响。然而,两种细胞系中的秘鲁68菌株的感染对用神经氨酸酶处理细胞敏感。这些数据表明,EV-D 68进入需要一种以上的细胞特异性分子,并且该分子取决于病毒基因型。该提案的目标是对编码参与EV-D 68细胞进入的分子的基因进行遗传筛选。为了鉴定EV-D 68的细胞受体,我们建议在感染EV-D 68之前使用CRISPR-Cas9方法遗传改变细胞群体,并鉴定不再支持病毒复制的细胞。从这些候选基因中,我们将确定哪些分子在病毒复制的早期步骤中起作用:细胞附着, 使用各种工具,包括先前发表的工作和生物信息学,进行细胞进入和病毒脱壳。通过将野生型基因重新引入相应的改变的细胞中,对确定具有编码跨膜蛋白和具有已知特征的蛋白质的基因的细胞进行补充,所述蛋白质相对于其他小核糖核酸病毒受体蛋白具有已知特征。将通过病毒复制评估细胞结合和对多种EV-D 68基因型感染的易感性。如果鉴定出一种以上的细胞蛋白介导EV-D 68感染,我们将通过研究不同基因型之间衣壳编码区交换的嵌合病毒来重新理解病毒-受体相互作用。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VINCENT R RACANIELLO其他文献

VINCENT R RACANIELLO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VINCENT R RACANIELLO', 18)}}的其他基金

Identifying quantitative trait loci that regulate enterovirus D68 pathogenesis using the Collaborative Cross
使用协作交叉识别调节肠道病毒 D68 发病机制的数量性状位点
  • 批准号:
    10113539
  • 财政年份:
    2020
  • 资助金额:
    $ 24万
  • 项目类别:
Role of astrocyte infection in viral neurovirulence
星形胶质细胞感染在病毒神经毒力中的作用
  • 批准号:
    10011753
  • 财政年份:
    2019
  • 资助金额:
    $ 24万
  • 项目类别:
Antagonism of Innate Immunity By Picornaviruses
小核糖核酸病毒对先天免疫的拮抗作用
  • 批准号:
    8402767
  • 财政年份:
    2012
  • 资助金额:
    $ 24万
  • 项目类别:
Antagonism of Innate Immunity By Picornaviruses
小核糖核酸病毒对先天免疫的拮抗作用
  • 批准号:
    8838042
  • 财政年份:
    2012
  • 资助金额:
    $ 24万
  • 项目类别:
Antagonism of Innate Immunity By Picornaviruses
小核糖核酸病毒对先天免疫的拮抗作用
  • 批准号:
    8464389
  • 财政年份:
    2012
  • 资助金额:
    $ 24万
  • 项目类别:
Antagonism of Innate Immunity By Picornaviruses
小核糖核酸病毒对先天免疫的拮抗作用
  • 批准号:
    8646879
  • 财政年份:
    2012
  • 资助金额:
    $ 24万
  • 项目类别:
Rhinovirus Pathogenesis and Host Range
鼻病毒发病机制和宿主范围
  • 批准号:
    7573588
  • 财政年份:
    2008
  • 资助金额:
    $ 24万
  • 项目类别:
Enterovirus Pathogenesis
肠道病毒发病机制
  • 批准号:
    7380955
  • 财政年份:
    2007
  • 资助金额:
    $ 24万
  • 项目类别:
Rhinovirus Pathogenesis and Host Range
鼻病毒发病机制和宿主范围
  • 批准号:
    6846229
  • 财政年份:
    2002
  • 资助金额:
    $ 24万
  • 项目类别:
Rhinovirus Pathogenesis and Host Range
鼻病毒发病机制和宿主范围
  • 批准号:
    7893161
  • 财政年份:
    2002
  • 资助金额:
    $ 24万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了